AYTU BIOPHARMA, INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
AYTU BIOPHARMA, INC (AYTU) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 6.56 thousand shares for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-09-22
- AYTU BIOPHARMA, INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 69.00 shares, a 96.85% decline year-over-year.
- AYTU BIOPHARMA, INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 1.67K shares.
- AYTU BIOPHARMA, INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 0.00 shares.
- AYTU BIOPHARMA, INC share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 4.82K shares.
- AYTU BIOPHARMA, INC share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2026 was 6.56K shares, a 29.20% increase from fiscal 2025.
- AYTU BIOPHARMA, INC share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 5.08K shares, a 63.12% increase from fiscal 2024.
- AYTU BIOPHARMA, INC share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 3.11K shares, a 1658.76% increase from fiscal 2023.
- AYTU BIOPHARMA, INC share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 177.00 shares, a 98.70% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 69.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | 1.74K shares derived: sum of 2 quarters · filed 2026-09-22 | 1.74K shares derived: sum of 3 quarters · filed 2026-09-22 | 6.56K shares 10-K · filed 2026-09-22 | |
| 2026-03-31 | 1.67K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | 1.67K shares derived: sum of 2 quarters · filed 2026-05-13 | 6.49K shares 10-Q · filed 2026-05-13 | 8.68K shares derived: sum of 4 quarters · filed 2026-05-13 | |
| 2025-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | 4.82K shares 10-Q · filed 2026-02-03 | 7.01K shares derived: sum of 3 quarters · filed 2026-02-03 | ||
| 2025-09-30 | 4.82K shares 10-Q · filed 2025-11-13 | 7.01K shares derived: sum of 2 quarters · filed 2025-11-13 | |||
| 2025-06-30 | 2.19K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | 5.08K shares 10-K · filed 2025-09-23 | |||
| 2025-03-31 | 2.89K shares 10-Q · filed 2025-05-14 | ||||
| 2024-06-30 | 2.41K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-26 | 2.50K shares derived: sum of 2 quarters · filed 2024-09-26 | 3.08K shares derived: sum of 3 quarters · filed 2024-09-26 | 3.11K shares 10-K · filed 2024-09-26 | |
| 2024-03-31 | 87.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | 668.00 shares derived: sum of 2 quarters · filed 2024-05-15 | 702.00 shares 10-Q · filed 2024-05-15 | 704.00 shares derived: sum of 4 quarters · filed 2024-05-15 | |
| 2023-12-31 | 581.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | 615.00 shares 10-Q · filed 2024-02-14 | 617.00 shares derived: sum of 3 quarters · filed 2024-02-14 | 692.00 shares derived: sum of 4 quarters · filed 2024-02-14 | |
| 2023-09-30 | 34.00 shares 10-Q · filed 2023-11-14 | 36.00 shares derived: sum of 2 quarters · filed 2023-11-14 | 111.00 shares derived: sum of 3 quarters · filed 2023-11-14 | 185.00 shares derived: sum of 4 quarters · filed 2023-11-14 | |
| 2023-06-30 | 2.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-12 | 77.00 shares derived: sum of 2 quarters · filed 2023-10-12 | 151.00 shares derived: sum of 3 quarters · filed 2023-10-12 | 177.00 shares 10-K · filed 2023-10-12 | |
| 2023-03-31 | 75.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | 149.00 shares derived: sum of 2 quarters · filed 2023-05-11 | 175.00 shares 10-Q · filed 2023-05-11 | 3.22K shares derived: sum of 4 quarters · filed 2023-05-11 | |
| 2022-12-31 | 74.00 shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-02-21 | 100.00 shares 10-Q · filed 2023-02-21 | 3.14K shares derived: sum of 3 quarters · filed 2023-02-21 | 4.24K shares derived: sum of 4 quarters · filed 2023-02-21 | |
| 2022-09-30 | 26.00 shares 10-Q/A · filed 2023-02-21 | 541.00 shares 10-Q · filed 2022-11-14 | 3.07K shares derived: sum of 2 quarters · filed 2023-02-21 | 4.17K shares derived: sum of 3 quarters · filed 2023-02-21 | 6.02K shares derived: sum of 4 quarters · filed 2023-02-21 |
| 2022-06-30 | 3.04K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | 4.14K shares derived: sum of 2 quarters · filed 2022-09-27 | 6.00K shares derived: sum of 3 quarters · filed 2022-09-27 | 13.64K shares 10-K · filed 2022-09-27 | |
| 2022-03-31 | 1.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | 2.95K shares derived: sum of 2 quarters · filed 2022-05-16 | 10.60K shares 10-Q · filed 2022-05-16 | ||
| 2021-12-31 | 1.86K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | 9.50K shares 10-Q · filed 2022-02-14 | |||
| 2021-09-30 | 7.64K shares 10-Q · filed 2021-11-15 | ||||
| 2021-03-31 | 2.53K shares 10-Q · filed 2021-05-17 | ||||
| 2020-12-31 | 2.00 shares 10-Q · filed 2021-02-11 | ||||
| 2017-03-31 | 1.35K shares 10-Q · filed 2017-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |